TNON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tenon Medical Inc (TNON) is not a strong buy for a beginner investor with a long-term strategy at this time. While the company has shown significant revenue growth in the latest quarter, its net income and EPS have deteriorated, indicating financial instability. Additionally, the technical indicators and trading trends do not suggest a compelling entry point, and there are no recent positive news or catalysts to support a bullish outlook. The lack of Intellectia Proprietary Trading Signals further diminishes the case for immediate investment.
The MACD is positive and expanding, indicating slight bullish momentum. RSI is in the neutral zone at 62.68, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price direction. Key support is at 0.743, and resistance is at 0.849. Pre-market price is 0.8152, down -2.97%, indicating bearish sentiment.
Revenue increased by 92.34% YoY in the latest quarter, and gross margin improved significantly to 68.67%, up 49.80% YoY.
Net income dropped by -8.26% YoY, and EPS declined sharply by -70.41% YoY. Pre-market price is down -2.97%, and there is a 55.56% chance of further price decline in the next day, week, and month. No recent news, trading trends, or congressional trading data to support positive sentiment.
In Q4 2025, revenue increased significantly to $1,481,000 (up 92.34% YoY), but net income dropped to -$2,832,000 (down -8.26% YoY). EPS fell to -0.29 (down -70.41% YoY), indicating worsening profitability. Gross margin improved to 68.67% (up 49.80% YoY), showing operational efficiency gains.
No analyst rating or price target changes available.
